Valrubicin

This classification denotes an anthracycline antibiotic with the molecular formula C34H36F3NO13, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 2C6NUM6878, chemically known as pentanoic acid, 2-((2s,4s)-1,2,3,4,6,11-hexahydro-2,5,12-trihydroxy-7-methoxy-6,11-dioxo-4-((2,3,6-trideoxy-3-((trifluoroacetylamino)-, alpha-l-lysohexopyranoxyl)oxy)-2-naphthacenyl)-2-oxoethyl ester but generally known as valrubicin, which bears US NIH Compound Identifier 41744. European Medicines Agency schedules Valrubicin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05075MIG. The term VALRUBICIN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 13 No. 1, 1999, List 41). World Health Organization schedules valrubicin in its Anatomical Therapeutic Chemical (ATC) Classification. Most nations schedule valrubicin under HS 29419000 and SITC 54139. As of Q4 2014, VALRUBICIN remains the US FDA Preferred Term for this commodity. Valrubicin bears US NLM identifiers UMLS ID C0068314 and NCI Concept Code C1340. SMILES: FC(F)(F)C(=O)NC1CC(OC2CC(O)(CC3C2C(O)C2C(C3O)C(=O)C3C(C2=O)C(OC)CCC3)C(=O)COC(=O)CCCC)OC(C1O)C.